Infant Bilirubin Phototherapy – The Breakthrough in Neonatal Care

Manifesting a milestone in neonatal care, Kalstein’s YR02195 and YR02194 Infant Bilirubin Phototherapy Unit models are innovative solutions that offer safety and efficiency in bilirubin therapy for newborns.ย 

Created with state-of-the-art LED light technology, both devices have an irradiation wavelength range of 300 to 550 nm which, together with their adjustable irradiation capacity from 1 to 99 levels, provide a versatile treatment platform, allowing irradiation settings of up to 3 000 uw/cm2. The power consumption of both models is relatively low, with a maximum of 50W. https://kalstein.ee/product/infant-bilirubin-phototherapy-unit-yr02195/

Technical Specifications and Function

Both models have an impressive effective lifetime of 5,000 hours and a nominal blue light lifetime of 20,000 hours, ensuring durability and long-term operations. They feature full duration timers and time countdowns that promote therapy accuracy. Their display range is from 0 to 9999 hours, which facilitates treatment monitoring.

They operate in an irradiation wavelength range of 400 to 550 nm and have a peak wavelength at 460 nm. In addition, these units incorporate an adjustable irradiance system that can be set in soft levels from 1 to 99.

Structure and Electrical Parts

The YR02195 is not specified to be height adjustable, however, the YR02194 model can be adjusted between 1100 and 1589 mm, which provides flexibility according to the patient’s needs. The dimension for the model YR02194 is 500 x 600 x (1 355 ~ 1 705) mm. https://kalstein.ee/product/infant-bilirubin-phototherapy-unit-yr02194/

Both units operate on AC (220ยฑ22) V (50ยฑ1) Hz power supply, 50W power consumption, and tolerate ambient temperature from 10 to 40ยฐC and ambient relative humidity up to 80%.ย 

Key Benefits

Kalstein’s infant bilirubin phototherapy units are designed with the goal of providing safe and effective therapy for newborns with hyperbilirubinemia. Their efficacy, accuracy and ease of use make these models an excellent choice for neonatal care. The lifespan and energy efficiency of these units make them a valuable and sustainable long-term investment for any healthcare institution.

In conclusion, with their advanced and effective technology, Kalstein’s YR02195 and YR02194 Infant Bilirubin Phototherapy Units are essential equipment for improving the health and well-being of newborns in any healthcare setting.